Spots Global Cancer Trial Database for locally recurrent cancer
Every month we try and update this database with for locally recurrent cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Bevacizumab and Pembrolizumab Combination in EBER-ISH Positive NPC | NCT03813394 | Locally Recurre... Metastatic Naso... | pembrolizumab bevacizumab | 21 Years - 99 Years | National University Hospital, Singapore | |
To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer | NCT04332549 | Metastatic Brea... Locally Recurre... | PICS (Reconstit... | 18 Years - | Sun Pharma Advanced Research Company Limited | |
To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer | NCT04332549 | Metastatic Brea... Locally Recurre... | PICS (Reconstit... | 18 Years - | Sun Pharma Advanced Research Company Limited |